A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza

Cell Reports

Volumn 11, Issue 12, 2015, Pages 1941-1952

  Piao, Wenji ^a   Shirey, Kari Ann ^a   Ru, Lisa W ^a   Lai, Wendy ^a   Szmacinski, Henryk ^a   Snyder, Greg A ^a   Sundberg, Eric J ^a   Lakowicz, Joseph R ^a   Vogel, Stefanie N ^a   Toshchakov, Vladimir Y ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; PEPTIDE; TIRAP PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR4 DECOY; TLR7 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DNA HELIX; DOWNSTREAM PROCESSING; FEMALE; H1N1 A PR 8 34 STRAIN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLUENZA; MACROPHAGE; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; VIRUS STRAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE; MUS;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLUENZA, HUMAN; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; PEPTIDES; RECEPTORS, INTERLEUKIN-1; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84933675709     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.05.035     Document Type: Article

References (60)

1. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999, 285:736-739.
2. Bonham K.S., Orzalli M.H., Hayashi K., Wolf A.I., Glanemann C., Weninger W., Iwasaki A., Knipe D.M., Kagan J.C. A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell 2014, 156:705-716.
3. Brandes M., Klauschen F., Kuchen S., Germain R.N. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 2013, 154:197-212.
4. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
5. Cole L.E., Laird M.H., Seekatz A., Santiago A., Jiang Z., Barry E., Shirey K.A., Fitzgerald K.A., Vogel S.N. Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling. J. Leukoc. Biol. 2010, 87:275-281.
6. Connolly D.J., O'Neill L.A. New developments in Toll-like receptor targeted therapeutics. Curr. Opin. Pharmacol. 2012, 12:510-518.
7. Couture L.A., Piao W., Ru L.W., Vogel S.N., Toshchakov V.Y. Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides. J. Biol. Chem. 2012, 287:24641-24648.
8. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
9. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
10. Enokizono Y., Kumeta H., Funami K., Horiuchi M., Sarmiento J., Yamashita K., Standley D.M., Matsumoto M., Seya T., Inagaki F. Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling. Proc. Natl. Acad. Sci. USA 2013, 110:19908-19913.
11. Gautam J.K., Ashish, Comeau L.D., Krueger J.K., Smith M.F. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling. J. Biol. Chem. 2006, 281:30132-30142.
12. Gay N.J., Keith F.J. Drosophila Toll and IL-1 receptor. Nature 1991, 351:355-356.
13. Gay N.J., Symmons M.F., Gangloff M., Bryant C.E. Assembly and localization of Toll-like receptor signaling complexes. Nat. Immunol. 2014, 2014:546-558.
14. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 2005, 353:38-52.
15. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
16. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002, 420:329-333.
17. Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y.H.C., Wang H., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249.
18. Iwasaki A., Pillai P.S. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 2014, 14:315-328.
19. Jin M.S., Lee J.O. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008, 29:182-191.
20. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T., Takeuchi O., Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
21. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
22. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
23. Kenny E.F., Talbot S., Gong M., Golenbock D.T., Bryant C.E., O'Neill L.A. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J. Immunol. 2009, 183:3642-3651.
24. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release. 2008, 132:171-183.
25. Larsen P.J., Fledelius C., Knudsen L.B., Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 2001, 50:2530-2539.
26. Lee S.M., Kok K.H., Jaume M., Cheung T.K., Yip T.F., Lai J.C., Guan Y., Webster R.G., Jin D.Y., Peiris J.S. Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection. Proc. Natl. Acad. Sci. USA 2014, 111:3793-3798.
27. Liu C., Swaidani S., Qian W., Kang Z., Sun P., Han Y., Wang C., Gulen M.F., Yin W., Zhang C., et al. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation. Sci. Signal. 2011, 4:ra72.
28. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 2000, 68:6398-6401.
29. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 2004, 101:5598-5603.
30. Lysakova-Devine T., Keogh B., Harrington B., Nagpal K., Halle A., Golenbock D.T., Monie T., Bowie A.G. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J. Immunol. 2010, 185:4261-4271.
31. Means T.K., Lien E., Yoshimura A., Wang S., Golenbock D.T., Fenton M.J. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 1999, 163:6748-6755.
32. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
33. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 1998, 2:253-258.
34. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
35. O'Neill L.A., Bryant C.E., Doyle S.L. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 2009, 61:177-197.
36. Oda S., Franklin E., Khan A.R. Poxvirus A46 protein binds to TIR domain-containing Mal/TIRAP via an α-helical sub-domain. Mol. Immunol. 2011, 48:2144-2150.
37. Ogus A.C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., Coskun M., Cilli A., Yegin O. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 2004, 23:219-223.
38. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 2000, 97:13766-13771.
39. Pawson T., Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003, 300:445-452.
40. Piao W., Ru L.W., Piepenbrink K.H., Sundberg E.J., Vogel S.N., Toshchakov V.Y. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain. Proc. Natl. Acad. Sci. USA 2013, 110:19036-19041.
41. Piao W., Vogel S.N., Toshchakov V.Y. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo. J. Immunol. 2013, 190:2263-2272.
42. Schröder N.W., Diterich I., Zinke A., Eckert J., Draing C., von Baehr V., Hassler D., Priem S., Hahn K., Michelsen K.S., et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 2005, 175:2534-2540.
43. Shirey K.A., Lai W., Scott A.J., Lipsky M., Mistry P., Pletneva L.M., Karp C.L., McAlees J., Gioannini T.L., Weiss J., et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 2013, 497:498-502.
44. Slack J.L., Schooley K., Bonnert T.P., Mitcham J.L., Qwarnstrom E.E., Sims J.E., Dower S.K. Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J. Biol. Chem. 2000, 275:4670-4678.
45. Sleep D., Cameron J., Evans L.R. Albumin as a versatile platform for drug half-life extension. Biochim. Biophys. Acta 2013, 1830:5526-5534.
46. Smith M.C., Gestwicki J.E. Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity. Expert Rev. Mol. Med. 2012, 14:e16.
47. Szmacinski H., Toshchakov V., Lakowicz J.R. Application of phasor plot and autofluorescence correction for study of heterogeneous cell population. J. Biomed. Opt. 2014, 19:046017.
48. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
49. Takeuchi O., Kawai T., Mühlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
50. Toshchakov V.Y., Vogel S.N. Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions. Expert Opin. Biol. Ther. 2007, 7:1035-1050.
51. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 2002, 3:392-398.
52. Toshchakov V.U., Basu S., Fenton M.J., Vogel S.N. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J. Immunol. 2005, 175:494-500.
53. Toshchakov V.Y., Fenton M.J., Vogel S.N. Cutting Edge: Differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. J. Immunol. 2007, 178:2655-2660.
54. Toshchakov V.Y., Szmacinski H., Couture L.A., Lakowicz J.R., Vogel S.N. Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: identification of the TLR4 Toll/IL-1 receptor domain dimerization interface. J. Immunol. 2011, 186:4819-4827.
55. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999, 401:811-815.
56. Vanhee P., Stricher F., Baeten L., Verschueren E., Lenaerts T., Serrano L., Rousseau F., Schymkowitz J. Protein-peptide interactions adopt the same structural motifs as monomeric protein folds. Structure 2009, 17:1128-1136.
57. Wang X., Smith C., Yin H. Targeting Toll-like receptors with small molecule agents. Chem. Soc. Rev. 2013, 42:4859-4866.
58. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2001, 2:346-352.
59. Xiong Y., Song C., Snyder G.A., Sundberg E.J., Medvedev A.E. R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J. Biol. Chem. 2012, 287:38327-38337.
60. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329.